SERKO LIMITED — Director's Dealing 2025

Sep 1, 2025

==> picture [119 x 33] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer:		Serko Limited
Date this disclosure made:		2 September 2025
Date of last disclosure:		4 August 2025
Director or senior manager giving disclosure
Full name(s):		Robert Clyde McConaghy
Name of listed issuer:		Serko Limited
Name of related body corporate (if applicable):		Not applicable
Position held in listed issuer:		Previous Director
Summary of acquisition or disposal of relevant interest(excluding specified derivatives)
Class of affected quoted financial products:		Ordinary shares in Serko Limited
Nature of the affected relevant interest(s):		Registered holder and beneficial owner ofshares by virtue of Mr McConaghy being atrustee (and beneficiary) of the PortofinoTrust.
For that relevant interest-
Number held in class before acquisition or disposal:		143,003.00
Number held in class after acquisition or disposal:		133,003.00
Current registered holder(s):		Mr McConaghy as trustee for Portofino Trust
Registered holder(s) once transfers are registered:		Unknown
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates:		1
Details of transactions requiring disclosure-
Date of transaction:		29 August 2025
Nature of transaction:		On-market share sale
Name of any other party or parties to the transaction (if known):		Not applicable.
The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. Ifthe consideration was not in cash and cannot be readily by converted into a cash value, describe theconsideration:		NZ$2.44 per share (based on theexchange rate of 1 AUD = 1.10999 NZD onthe date of the transaction)
Number of financial products to which the transaction related:		10,000 ordinary shares
If the issuer has a financial products trading policy that prohibits directors or senior managers fromtrading during any period without written clearance (a closed period) include the following details—
Whether relevant interests were acquired or disposed of during a closed period:		No
Whether prior written clearance was provided to allow the acquisition or disposal to proceed during theclosed period:		Not applicable
Date of the prior written clearance (if any):		Not applicable
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:		Ordinary shares
Nature of relevant interest:		Registered holder and beneficial owner
_For that relevant interest,- _
Number held in class:		1,091
Current registered holder(s):		Robert Clyde McConaghy
For a derivative relevant interest,-
Type of derivative:		Not applicable

Details of derivative,-

Details of derivative,-	Details of derivative,-	Details of derivative,-	Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial products (ifany):					Not applicable
A statement as to whether the derivative is cash settled or physically settled:					Not applicable
Maturity date of the derivative (if any):					Not applicable
Expiry date of the derivative (if any):					Not applicable
The price's specified terms (if any):					Not applicable
Any other details needed to understand how the amount of the consideration payable under thederivative or the value of the derivative is affected by the value of the underlying financial products:					Not applicable
	derivative is affected by the value of the underlyi	ng financial products:
For that derivative relevant i
	nterest,-
Parties to the derivative:					Not applicable
If the director or senior manaderivative:	ger is not a party to the derivative, the nature of t	he relevant interest in	the		Not applicable
Certification
I certify that, to the best of mcorrect and that I am duly au	y knowledge and belief, the information containe	d in this disclosure is
	thorised to make this disclosure by all persons for	whom it is made.
Signature of person authoris
	ed to sign on behalf of director or officer:
Date of signature:					2 September	2025
Name and title of authorised	person:				Isla Dentice-W	ood, Company Secretary